Radio Frequency Identification (RFID) in Pharmaceuticals - Supply Chain Security Concerns Provide Impetus for RFID Adoption - GBI Research Reports

Radio Frequency Identification (RFID) in Pharmaceuticals - Supply Chain Security Concerns Provide Impetus for RFID Adoption

Radio Frequency Identification (RFID) in Pharmaceuticals - Supply Chain Security Concerns Provide Impetus for RFID Adoption - GBI Research Reports
Radio Frequency Identification (RFID) in Pharmaceuticals - Supply Chain Security Concerns Provide Impetus for RFID Adoption
Published Feb 01, 2010
89 pages — Published Feb 01, 2010
Price US$ 3,500.00  |  Buy this Report Now

About This Report

  
Abstract:

SummaryGBI Research, the leading business intelligence provider, has released its latest research, 'Radio Frequency Identification (RFID) in Pharmaceuticals - Supply Chain Security Concerns Provides Impetus for RFID Adoption.' It provides key data and analysis of the major factors affecting the market for RFID in the pharmaceuticals industry. This pharmaceutical and healthcare report also analyzes the strengths, weaknesses, opportunities and threats in the RFID market within the pharmaceutical industry and the key market drivers and barriers to the adoption of RFID in the industry.The report is based on proprietary databases, primary and secondary research, and in-house analysis by GBI Research's team of industry experts.The global market for Radio Frequency Identification (RFID) products and services in the pharmaceutical industry was valued at $112m in 2008 and is expected to grow to $884m in 2015 at a CAGR of 34% over the same period. The market for RFID hardware is the largest at the initial stages of adoption in the pharmaceutical industry. Service providers are gaining market share by integrating their services with one-stop solutions. The share of hardware in the RFID market is estimated to be 60% in 2008 and includes tags, readers and label printers. The share of software and services in the RFID market is estimated to be 40% in 2008. RFID services include installation, integration, training, maintenance and IT support. GBI Research's analysis suggests that the RFID technology is in the early stages of adoption within the pharmaceutical industry. The market for RFID in pharmaceuticals is hampered by low adoption rates due to apprehensions over high investments and the lack of a clear business case. However, solutions for the pharmaceutical industry are evolving to address the concerns responsible for the slow growth. RFID vendors are offering pilot kits for the pharmaceutical industry to test and evaluate RFID technology so that clients can understand the technology's costs and benefits. RFID adoption rate will be low initially due to budget restrictions in the pharmaceutical industry as a result of the global recession and subsequent cost cutting measures. However, the adoption rate is expected to increase rapidly due to mandates from retailers like Wal-Mart and from regulatory authorities like the California Board of Pharmacy for the implementation of e-Pedigree in the supply chain. In essence, RFID is the most promising solution for the elimination of counterfeits in the pharmaceutical supply chain. However, realization of the technology's potential benefits is possible only if apprehensions about the initial costs of implementation, return-on-investment and a weak business case are addressed.ScopeThe scope of this report includes: - Analysis of the opportunities and challenges for Radio Frequency Identification technology providers in the pharmaceuticals industry- Market revenues and forecasts for RFID solutions in the global pharmaceutical industry from 2008 to 2015- The market for RFID hardware, software and services in the pharmaceutical industry including track-and-trace solutions and e-Pedigree solutions- Qualitative analysis of the market drivers, barriers, future outlook and challenges for RFID adoption in the pharmaceutical industry- Coverage of key geographies including the US, Germany, the UK, France, Spain, Italy and Japan- Analysis of technology adoption framework for RFID hardware, software and services in the pharmaceutical industry- Information and analysis on the competitive landscape and the leading market players such as Alien Technologies, SupplyScape, Zebra Technologies Corporation, TAGSYS Inc and IBMReasons to buyThe report will enhance your decision making and will enable you to:- Formulate strategies to increase your company's growth by understanding the new growth opportunities for RFID technologies within the pharmaceutical market- Draft effic

  
Source:
Document ID
GBIHC013MR
Industry
Format:
PDF Adobe Acrobat
Buy Now

GBI Research Reports—GBI Research covers worldwide markets and issues, supplies actionable data and forecasts and is driven by industry leaders' insights. GBI Research provides a broad spectrum of reports across the healthcare and energy industries and its online offering is easy to navigate - a comprehensive resource for business information needs.

About the Author


Cite this Report

  
MLA:
GBI Research Reports. "Radio Frequency Identification (RFID) in Pharmaceuticals - Supply Chain Security Concerns Provide Impetus for RFID Adoption" Feb 01, 2010. Alacra Store. Nov 16, 2026. <http://www.alacrastore.com/storecontent/GBI-Research-Reports/Radio-Frequency-Identification-RFID-in-Pharmaceuticals-Supply-Chain-Security-Concerns-Provide-Impetus-for-RFID-Adoption-2115-29>
  
APA:
GBI Research Reports. (2010). Radio Frequency Identification (RFID) in Pharmaceuticals - Supply Chain Security Concerns Provide Impetus for RFID Adoption Feb 01, 2010. New York, NY: Alacra Store. Retrieved Nov 16, 2026 from <http://www.alacrastore.com/storecontent/GBI-Research-Reports/Radio-Frequency-Identification-RFID-in-Pharmaceuticals-Supply-Chain-Security-Concerns-Provide-Impetus-for-RFID-Adoption-2115-29>
  
US$ 3,500.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Market Research from one place.